Multidrug-Resistant Plasmodium vivax Associated with Severe and Fatal Malaria: A Prospective Study in Papua, Indonesia

Abstract

BACKGROUND: Multidrug-resistant Plasmodium vivax (Pv) is widespread in eastern Indonesia, and emerging elsewhere in Asia-Pacific and South America, but is generally regarded as a benign disease. The aim of the study was to review the spectrum of disease associated with malaria due to Pv and P. falciparum (Pf) in patients presenting to a hospital in Timika, southern Papua, Indonesia. METHODS AND FINDINGS: Data were prospectively collected from all patients attending the outpatient and inpatient departments of the only hospital in the region using systematic data forms and hospital computerised records. Between January 2004 and December 2007, clinical malaria was present in 16% (60,226/373,450) of hospital outpatients and 32% (12,171/37,800) of inpatients. Among patients admitted with slide-confirmed malaria, 64% of patients had Pf, 24% Pv, and 10.5% mixed infections. The proportion of malarial admissions attributable to Pv rose to 47% (415/887) in children under 1 y of age. Severe disease was present in 2,634 (22%) inpatients with malaria, with the risk greater among Pv (23% [675/2,937]) infections compared to Pf (20% [1,570/7,817]; odds ratio [OR] = 1.19 [95% confidence interval (CI) 1.08-1.32], p = 0.001), and greatest in patients with mixed infections (31% [389/1,273]); overall p < 0.0001. Severe anaemia (haemoglobin < 5 g/dl) was the major complication associated with Pv, accounting for 87% (589/675) of severe disease compared to 73% (1,144/1,570) of severe manifestations with Pf (p < 0.001). Pure Pv infection was also present in 78 patients with respiratory distress and 42 patients with coma. In total 242 (2.0%) patients with malaria died during admission: 2.2% (167/7,722) with Pf, 1.6% (46/2,916) with Pv, and 2.3% (29/1260) with mixed infections (p = 0.126). CONCLUSIONS: In this region with established high-grade chloroquine resistance to both Pv and Pf, Pv is associated with severe and fatal malaria particularly in young children. The epidemiology of P. vivax needs to be re-examined elsewhere where chloroquine resistance is increasing.

Cited by papers we hold 24

• SNP barcodes provide higher resolution than microsatellite markers to measure Plasmodium vivax population genetics · 2020
  Not checked
• Plasmodium vivax in the Era of the Shrinking P. falciparum Map · 2020
  No notice
• An Overview of Drug Resistance in Protozoal Diseases · 2019
  No notice
• Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens · 2017
  No notice
• Global Epidemiology of Plasmodium vivax · 2016
  No notice
• Parasite Biomass-Related Inflammation, Endothelial Activation, Microvascular Dysfunction and Disease Severity in Vivax Malaria · 2015
  No notice
• Antimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network · 2015
  No notice
• Geographical variation in Plasmodium vivax relapse · 2014
  No notice
• Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis · 2014
  No notice
• Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900 · 2014
  No notice
• Is Plasmodium vivax Malaria a Severe Malaria?: A Systematic Review and Meta-Analysis · 2014
  No notice
• Limitations of microscopy to differentiate Plasmodium species in a region co-endemic for Plasmodium falciparum, Plasmodium vivax and Plasmodium knowlesi · 2013
  No notice
• Major Burden of Severe Anemia from Non-Falciparum Malaria Species in Southern Papua: A Hospital-Based Surveillance Study · 2013
  No notice
• Functional analysis of Plasmodium vivax dihydrofolate reductase-thymidylate synthase genes through stable transformation of Plasmodium falciparum. · 2012
  Not checked
• A Long Neglected World Malaria Map: Plasmodium vivax Endemicity in 2010 · 2012
  No notice
• The anaemia of Plasmodium vivax malaria · 2012
  No notice
• CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA · 2012
  No notice
• Duffy Negative Antigen Is No Longer a Barrier to Plasmodium vivax – Molecular Evidences from the African West Coast (Angola and Equatorial Guinea) · 2011
  No notice
• The International Limits and Population at Risk of Plasmodium vivax Transmission in 2009 · 2010
  No notice
• Severe Plasmodium vivax Malaria, Brazilian Amazon · 2010
  No notice

and 4 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.